Michael Nally
Chief Executive Officer, Director at Generate Biomedicines, Inc. (GENB)
Michael Nally has filed 42 insider reports with the SEC since February 2021, as director at Ppg Industries Inc (PPG), chief Executive Officer and director at Generate Biomedicines, Inc. (GENB) and officer at Merck & Co., Inc. (MRK). In the last 12 months Michael Nally bought $240K of stock on the open market. The latest filing, on September 14, 2026, reports grant or award at Ppg Industries Inc (PPG).
Schedule 13D and 13G filings by Michael Nally
- 2026-05-15GENB SCHEDULE 13G filed by Generate Biomedicines Inc.Schedule 13G
- Filings
- 42
- Companies
- 3
- Bought on market
- $240K
- Sold on market
- None
Companies where Michael Nally is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince February 2021 | 264 | $122.78 | Sep 14, 2026 | ||||
| Chief Executive Officer, Director | 572,707 | $240K | $12.00 | $10.38-13% | Mar 6, 2026 | ||
| Officer | 19,630 | $137.78 | Mar 2, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Sep 11, 2026PPGSEC Form 4 filed by Director Nally MichaelForm 4Grant or award
- Jun 12, 2026PPGSEC Form 4 filed by Director Nally MichaelForm 4Grant or award
- Apr 16, 2026PPGSEC Form 4 filed by Nally MichaelForm 4Grant or awardExercise or conversion of a derivative
- Mar 12, 2026PPGSEC Form 4 filed by Director Nally MichaelForm 4Grant or award
- Mar 4, 2026+$240KGENBChief Executive Officer Nally Michael bought $240,000 worth of shares (20,000 units at $12.00), increasing direct ownership by 4% to 572,707 unitsForm 4Open-market purchase
- Mar 2, 2026GENBChief Executive Officer Nally Michael converted options into 658,327 sharesForm 4Grant or awardConversion of a derivative
- Dec 12, 2025PPGSEC Form 4 filed by Director Nally MichaelForm 4Grant or award
- Sep 12, 2025PPGSEC Form 4 filed by Director Nally MichaelForm 4Grant or award
- Jun 12, 2025PPGSEC Form 4 filed by Director Nally MichaelForm 4Grant or award
- Apr 17, 2025PPGSEC Form 4 filed by Director Nally MichaelForm 4Grant or awardExercise or conversion of a derivative
- Mar 12, 2025PPGSEC Form 4 filed by Director Nally MichaelForm 4Grant or award
- Jan 2, 2025PPGSEC Form 4 filed by Director Nally MichaelForm 4Grant or award
- Dec 12, 2024PPGSEC Form 4 filed by Director Nally MichaelForm 4Grant or award
- Oct 1, 2024PPGSEC Form 4 filed by Director Nally MichaelForm 4Grant or award
- Sep 12, 2024PPGSEC Form 4 filed by Director Nally MichaelForm 4Grant or award
- Jul 1, 2024PPGSEC Form 4 filed by Director Nally MichaelForm 4Grant or award
- Jun 12, 2024PPGSEC Form 4 filed by Director Nally MichaelForm 4Grant or award
- Apr 18, 2024PPGSEC Form 4 filed by Nally MichaelForm 4Grant or awardExercise or conversion of a derivative
- Mar 12, 2024PPGSEC Form 4 filed by Nally MichaelForm 4Grant or award
- Jan 2, 2024PPGSEC Form 4 filed by Nally MichaelForm 4Grant or award
- Dec 12, 2023PPGSEC Form 4 filed by Nally MichaelForm 4Grant or award
- Oct 2, 2023PPGSEC Form 4 filed by Nally MichaelForm 4Grant or award
- Sep 12, 2023PPGSEC Form 4 filed by Nally MichaelForm 4Grant or award
- Jul 3, 2023PPGSEC Form 4 filed by Nally MichaelForm 4Grant or award
- Jun 12, 2023PPGSEC Form 4 filed by Nally MichaelForm 4Grant or award
- Apr 20, 2023PPGSEC Form 4 filed by Nally MichaelForm 4Grant or awardExercise or conversion of a derivative
- Mar 10, 2023PPGSEC Form 4 filed by Nally MichaelForm 4Grant or award
- Jan 3, 2023PPGSEC Form 4 filed by Nally MichaelForm 4Grant or award
- Dec 12, 2022PPGSEC Form 4 filed by Nally MichaelForm 4Grant or award
- Sep 12, 2022PPGSEC Form 4 filed by Nally MichaelForm 4Grant or award
- Jul 1, 2022PPGSEC Form 4 filed by Nally MichaelForm 4Grant or award
- Jun 10, 2022PPGSEC Form 4 filed by Nally MichaelForm 4Grant or award
- Apr 21, 2022PPGSEC Form 4 filed by Nally MichaelForm 4Grant or awardExercise or conversion of a derivative
- Mar 11, 2022PPGSEC Form 4 filed by Nally MichaelForm 4Grant or award
- Dec 10, 2021PPGSEC Form 4 filed by Nally MichaelForm 4Grant or award
- Sep 10, 2021PPGSEC Form 4 filed by Nally MichaelForm 4Grant or award
- Jun 11, 2021PPGSEC Form 4 filed by Nally MichaelForm 4Grant or award
- Apr 15, 2021PPGSEC Form 4 filed by Nally MichaelForm 4Grant or award
- Apr 14, 2021PPGSEC Form 4: Nally Michael exercised 164 units of Common Stock at a strike of $0.00, increasing direct ownership by 164% to 264 unitsForm 4Exercise or conversion of a derivative
- Mar 26, 2021PPGSEC Form 4 filed by Michael NallyForm 4Grant or award
- Feb 26, 2021MRKSEC Form 4: Michael Nally was granted 7,127 units of Common Stock, increasing ownership by 57% to 19,630 unitsForm 4Grant or award
- Feb 18, 2021PPGSEC Form 3: Michael Nally claimed ownership of 100 units of Common StockForm 3New insider
Compare Michael Nally with
- Michael Nally vs Richard R. DeLuca1 shared
- Michael Nally vs Robert L. Massy1 shared
- Michael Nally vs Timothy M Knavish1 shared
- Michael Nally vs Chancey E. Hagerty1 shared
- Michael Nally vs Juliane M. Hefel1 shared
- Michael Nally vs Kevin D. Braun1 shared
Other insiders at the same companies
- Richard R. DeLucaMRK
- Robert L. MassyPPG
- Timothy M KnavishPPG
- Kevin D. BraunPPG
- Juliane M. HefelPPG
- Chancey E. HagertyPPG
- Alisha BellezzaPPG
- Jamie A. BeggsPPG
- Frances ArnoldGENB
- Paul J DiazMRK
- Guillermo NovoPPG
- Kathy Lynn FortmannPPG
- Christine E SeidmanMRK
- Surendralal Lanca KarsanbhaiMRK
- Mary Ellen CoeMRK
- Amy R. EricsonPPG
Questions about Michael Nally
- What is Michael Nally's role at Generate Biomedicines, Inc.?
- Michael Nally reports to the SEC as chief Executive Officer and director at Generate Biomedicines, Inc. (GENB), according to the latest filing on March 6, 2026. Michael Nally has also filed as director at Ppg Industries Inc (PPG) and officer at Merck & Co., Inc. (MRK).
- How many shares does Michael Nally own?
- After the latest filing that states it, Michael Nally directly owned 264 shares of Ppg Industries Inc (PPG), 572,707 shares of Generate Biomedicines, Inc. (GENB) and 19,630 shares of Merck & Co., Inc. (MRK). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Michael Nally bought or sold stock recently?
- The most recent open-market purchase was on March 4, 2026: bought 20,000 shares of Generate Biomedicines, Inc. (GENB) for $240K at an average of $12.00.
- How do I get alerts when Michael Nally files?
- Follow Michael Nally on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Michael Nally filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Michael Nally (SEC CIK 0001763945). Totals count each trade once, skipping amendments whose original is on file, from Feb 19, 2021 on. View on SEC EDGAR